SynBioBeta 2026. May 4-7, San Jose, California
Xaira's CEO and GSK's SVP of AI are on the same main stage panel. Boltz's founder is presenting alongside Novo Nordisk's VP of Computational Drug Design. NVIDIA and OpenAI are in the building. So are the startups building foundation models, virtual cells, and AI-designed therapeutics, ingredients, chemicals, and materials that didn't exist two years ago.
SynBioBeta is where the people building at the intersection of AI and biology present what they've built, and where the people funding, buying, and competing with them come to see it.
The Startups Founders to Meet, Fund and Partner with.
Funders writing checks and looking for their next company.
And the BD and R&D Leads
That Will Be Your Customers and Partners:
Who’s Coming to SynBioBeta?

Eric Schmidt
Former CEO

"For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta."

Celestine Schnugg
Founder


Surge Biswas
Founder


Jacob Glanville
Founder & CEO


Bill Tai
Co-founder

Ola Wlodek
CEO


Steve Jurvetson
Co-Founder


















































































































































